PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Blood vessel mapping reveals 4 new 'ZIP codes'

Targeting specific addresses could help fight cancer, obesity and other diseases

2011-10-25
(Press-News.org) HOUSTON - A research team led by scientists from The University of Texas MD Anderson Cancer Center have discovered four new "ZIP codes" in their quest to map the vast blood vessel network of the human body.

The study, published online the week of Oct. 24 in the Proceedings of the National Academy of Sciences, brings science one step closer to the goal of using the vascular system to personalize cancer therapy, as well as fight obesity, heart disease and other disorders. Researchers also found that some addresses are shared in vasculature across the board instead of always being organ-specific.

The study is part of ongoing research to identify specific and unique addresses, or ZIP codes, within the body's vascular system and use them to develop diagnostic, imaging and therapeutic strategies. Husband-and-wife research team Wadih Arap, M.D., Ph.D., and Renata Pasqualini, Ph.D., professors at the David H. Koch Center for Applied Research of Genitourinary Cancers at MD Anderson, pioneered the concept and were senior authors of the paper.

"By identifying vascular ZIP codes, we bring medicine closer to the ultimate goal of targeted therapies," Pasqualini said.

Innovative methods help investigation

This study supports the Arap-Pasqualini lab's ongoing research to show blood vessels are more than a uniform and ubiquitous "pipeline" that serves the circulatory system.

More than a decade ago, the group pioneered a screening technique that employs billions of viral particles, called phage, to discover, validate and use blood vessel diversity. The particles are packaged with small fragments of proteins called peptides that act as ligands. When injected into the body, they bind to specific receptors in the blood vessels and organs.

"This process is like a 'molecular mass mailing' to all addresses in the body," Arap said. "The peptides travel until they find a target and bind to it, then with our novel technology we recover and identify them. Knowing the characteristics of the peptides and where they attach can help us understand the vascular system's molecular makeup and develop therapies focusing on disease sites."

This new study was the first in which researchers evaluated the molecular repertoire of protein diversity in several patients, targeting multiple organs at once.

In three cancer patients, serial rounds of peptide collection were followed by biopsies from various tissues to determine where and how the peptides homed, which enabled the enrichment of targeting peptides for identifying ligand-receptors. After systemic delivery of a peptide library to the first patient, phage were recovered from organs, pooled and serially screened in two subsequent patients. Large-scale sequencing was then performed.

"This uncovered a new twist for the vascular map," Pasqualini said. "To this point, we had seen mainly addresses that were organ and tissue specific. Because of this synchronized method, we discovered some markers are vascular-associated at multiple sites."

Shared addresses surprise researchers

Analysis revealed four native ligand-receptors, three of which were previously unrecognized.

Two are shared among multiple tissues (integrin a4/annexin A4 and cathepsin B/apolipoprotein E3) and the other two have a restricted and specific distribution in normal tissue (prohibitin/annexin A2 in white fat tissue) or cancer (RAGE/leukocyte proteinase-3 in bone metastases).

The discovery of shared addresses especially intrigued researchers.

"No one knew about the novel aspect surrounding these particular proteins, and the fact that they can interact and come together to serve a common purpose," Pasqualini said. "There are likely to be many more."

A tissue-specific vascular-targeting system, comprising ANXA2 and prohibitin, was found as a ligand-receptor in human white adipose (fat) tissue vasculature. In earlier research, targeting of prohibitin with an apoptotic agent caused dramatic weight loss in obese rodents. The lab is applying to the Food and Drug Administration (FDA) to conduct a clinical trial for a new drug that will test this principle for weight loss in humans.

Moving the impact forward

This project establishes that large-scale study of the human vasculature can uncover many unidentified or unique molecular networks that can contribute to the treatment of many diseases.

"This endeavor and the applications of our findings are exciting," Arap said. "There are going to be many more receptors and many levels of diversity. We've just scratched the surface."

Translational applications, such as first-in-man clinical trials, have started within MD Anderson. The FDA has granted a safe-to-proceed status for the first vascular-targeted Investigational New Drug (IND). Three other drugs are in pre-IND stage, and several others are in pre-clinical laboratory phase.

"I believe these strategies to identify therapeutic targets on the vasculature are truly innovative both from a scientific and clinical perspective," said David Cheresh, Ph.D., associate director for Translational Research at the University of California, San Diego Cancer Center and noted authority on angiogenesis and cancer metastasis. "Identifying such targets will ultimately pave the way for the next generation of smart/targeted cancer therapies."

MD Anderson and some of its researchers, including Arap and Pasqualini, have equity positions in drug-development companies Alvos Therapeutics and Ablaris Therapeutics, which are subjected to certain restrictions under institutional policy. MD Anderson manages and monitors the terms of these arrangements in accordance with its conflict-of-interest policy.

###

Co-authors from MD Anderson's David H. Koch Center are first authors Fernanda Staquicini, Ph.D., Marina Cardó-Vila, Ph.D., and Mikhail Kolonin, Ph.D. Additional authors include Julianna Edwards; Diana Nunes, Ph.D., and Emmanuel Dias-Neto, Ph.D., Eleni Efstathiou, M.D., Ph.D.; Jessica Sun, and Christopher Logothetis, M.D.

Other MD Anderson contributors include Anna Sergeeva, Ph.D., Department of Stem Cell Transplantation; Shi-Ming Tu, M.D., Department of Genitourinary Medical Oncology; Jeffrey Gershenwald, M.D., Department of Surgical Oncology; Jeffrey Molldrem, M.D., Department of Stem Cell Transplantation; Anne Flamm, J.D., Department of Clinical Ethics ; Erkki Koivunen, Ph.D., Department of Leukemia; Rebecca Pentz, Ph.D., Department of Clinical Ethics; Patricia Troncoso, M.D., Department of Pathology; Kim-Ahn Do, Ph.D., Department of Biostatistics; Gregory Botz, M.D., Department of Critical Care; and Michael Wallace, M.D., Department of Diagnostic Radiology.

Additional contributors included Martin Trepel, M.D., University Medical Center of Hamburg; Nalvo Almeida, Ph.D., and João Setubal, Ph.D., Virginia Bioinformatics Institute and Department of Computer Science, Virginia Polytechnic University; Stan Krajewski, M.D., Ph.D., at The Sanford-Burnham Medical Research Institute; Richard Sidman, M.D., (corresponding author), Beth Israel Deaconess Medical Center and Harvard Medical School; Dolores Cahill, Ph.D., and David O'Connell, Ph.D., Conway Institute of Biomedical and Biomolecular Science, University College Dublin.

This work was funded by grants from the National Institutes of Health, National Cancer Institute, the U.S. Department of Defense, AngelWorks, the Gillson-Longenbaugh Foundation and the Marcus Foundation.

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For eight of the past 10 years, including 2011, MD Anderson has ranked No. 1 in cancer care in "Best Hospitals," a survey published annually in U.S. News & World Report.

END



ELSE PRESS RELEASES FROM THIS DATE:

Antidepressant linked to developmental brain abnormalities in rodents

2011-10-25
A study by researchers at the University of Mississippi Medical Center and the University of California, San Francisco shows that rats given a popularly prescribed antidepressant during development exhibit brain abnormalities and behaviors characteristic of autism spectrum disorders. The findings suggest that taking a certain class of antidepressants known as selective serotonin reuptake inhibitors – SSRIs – during pregnancy might be one factor contributing to a dramatic rise in these developmental disorders in children. "We saw behaviors in the treated rats and neurological ...

Local TV news: Sharing agreements mean less original content and possible monopoly violations

Local TV news: Sharing agreements mean less original content and possible monopoly violations
2011-10-25
Watching local TV news can lead to déjà vu. During the past decade, a growing number of local television stations have entered into agreements together – to share video footage, reporters, anchors and even full newscasts. A new report by the University of Delaware's Center for Community Research and Service looks at the impact of these possibly monopolistic agreements on local media markets and on the principles the federal government uses to regulate the broadcast industry: diversity, competition and localism. Danilo Yanich, author of the report and associate professor ...

Penny Stock Crew's 4 Tips on How to Invest in Penny Stocks!

2011-10-25
1. Penny stocks cost a penny for a reason. While we all dream about investing in the next Microsoft or the next Home Depot, but the truth is, the odds of you finding that once in a decade success story are slim. These companies are either starting out or purchased a shell company because it was cheaper than an IPO. This doesn't make them a bad investment. 2. Trading volumes. Look for a consistent volume of shares being traded. Looking at the average volume can be misleading. If ABC trades 1 million shares today, and doesn't trade for the rest of the week, the ...

Rural women more likely to be diagnosed with most serious form of breast cancer

2011-10-25
COLUMBIA, Mo.– Women living in rural areas face unique challenges concerning health and wellness issues. Now, an MU researcher has found that rural women are more likely than women living in cities to be diagnosed with late-stage breast cancer, the most severe form of the disease. "The stage at which the cancer is diagnosed has a tremendous impact on the type of treatment, recovery and survivability," said Faustine Williams, a doctoral student in the Department of Rural Sociology in the College of Agriculture, Food and Natural Resources. "Finding ways to identify and ...

Gene variation predicts rate of age-related decline in mental performance, Stanford study

2011-10-25
STANFORD, Calif. - A tiny difference in the coding pattern of a single gene significantly affects the rate at which men's intellectual function drops with advancing age, investigators at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System have learned. In a study to be published online Oct. 25 in Translational Psychiatry, the researchers tested the skills of experienced airplane pilots and found that having one version of the gene versus the other version doubled the rate at which the participants' performance declined over ...

CyberlinkASP to Offer Hosted Virtual Desktop in Europe

2011-10-25
CyberlinkASP, the leader in hosted virtual desktop solutions, today announced that it has expanded its data center facilities into London and will begin providing hosted virtual desktop services across the EMEA. CyberlinkASP will implement its turnkey virtual private cloud and Citrix based technologies to support the mission critical IT component(s) of firms across Europe. CyberlinkASP currently hosts, manages and supports virtual desktops for hundreds of SMB's and thousands of end users across the United States. CyberlinkASP's engineering staff, help desk and sophisticated ...

Quality-of-life for women an issue: in some matters of the heart, women do not fare as well as men

2011-10-25
Vancouver – A Heart and Stroke Foundation study has found that women under age 55 fare worse than their male counterparts following a heart attack – and their health status declines more than that of their male counterparts after one month. The AMI55 study found that women between the ages of 20 and 55 had significantly worse physical limitations, more recurrences of chest pain, and worse quality of life than men one month after a heart attack – and, compared to their baseline scores, declined in the areas of physical limitations and recurrences of chest pain. Among men, ...

Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease

2011-10-25
Vancouver – A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery. "Our discovery shifts how we think about AS by looking at a new pathway which both prevents and reverses calcification," says Dr. Pibarot, a professor at Laval University and Canada Research ...

Young, apparently healthy -- and at risk of heart disease

2011-10-25
Vancouver – Atherosclerosis – or buildup of fat in the walls of arteries − is thought of as a disorder of older people but it affects a large number of young men and women, according to a new Heart and Stroke Foundation study. "The proportion of young, apparently healthy adults who are presumably 'the picture of health' who already have atherosclerosis is staggering," says Dr. Eric Larose, an interventional cardiologist at the Institut universitaire de cardiologie et de pneumologie de Québec and an assistant professor at Université Laval. Atherosclerosis can eventually ...

The Generation X Report: U-M survey paints a surprisingly positive portrait

2011-10-25
ANN ARBOR, Mich.---They've been stereotyped as a bunch of insecure, angst-ridden, underachievers. But most members of Generation X are leading active, balanced and happy lives, according to a long-term University of Michigan survey. "They are not bowling alone," said political scientist Jon Miller, author of The Generation X Report. "They are active in their communities, mainly satisfied with their jobs, and able to balance work, family, and leisure." Miller directs the Longitudinal Study of American Youth at the U-M Institute for Social Research. The study, funded ...

LAST 30 PRESS RELEASES:

Einstein Probe releases its Science White Paper

Music-based therapy may improve depressive symptoms in people with dementia

No evidence that substituting NHS doctors with physician associates is necessarily safe

At-home brain speed tests bridge cognitive data gaps

CRF appoints Josep Rodés-Cabau, M.D., Ph.D., as editor-in-chief of structural heart: the journal of the heart team

Violent crime is indeed a root cause of migration, according to new study

Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment

Impact of COVID-19 on education not going away, UM study finds

School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods

Three Speculum articles recognized with prizes

ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology

Incarcerated people are disproportionately impacted by climate change, CU doctors say

ESA 2025 Graduate Student Policy Award Cohort Named

Insomnia, lack of sleep linked to high blood pressure in teens

Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults

Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk

Large study of dietary habits suggests more plant oils, less butter could lead to better health

Butter and plant-based oils intake and mortality

20% of butterflies in the U.S. have disappeared since 2000

Bacterial ‘jumping genes’ can target and control chromosome ends

Scientists identify genes that make humans and Labradors more likely to become obese

Early-life gut microbes may protect against diabetes, research in mice suggests

Study raises the possibility of a country without butterflies

Study reveals obesity gene in dogs that is relevant to human obesity studies

A rapid decline in US butterfly populations

Indigenous farming practices have shaped manioc’s genetic diversity for millennia

Controlling electrons in molecules at ultrafast timescales

Tropical forests in the Americas are struggling to keep pace with climate change

Brain mapping unlocks key Alzheimer’s insights

Clinical trial tests novel stem-cell treatment for Parkinson’s disease

[Press-News.org] Blood vessel mapping reveals 4 new 'ZIP codes'
Targeting specific addresses could help fight cancer, obesity and other diseases